Treating cancer - a new approach

General
1

For decades, cancer treatment has meant one thing, killing the cells before they kill you. A team in South Korea just proved there’s a second option nobody had systematically pulled off before, talking the cells back into behaving normally again.

Researchers at KAIST, led by Professor Kwang-Hyun Cho, focused on a strange biological fact: when a normal cell turns cancerous, it doesn’t transform into something alien.

It actually slides backward along its own developmental path, losing the specialized identity it once had, similar to an adult forgetting everything it learned since childhood. If that process runs in one direction, the team reasoned, maybe it could be pushed back the other way.

To find out how, they built what they call a digital twin, a detailed computer simulation of the gene network that guides normal colon cells as they mature. Running simulations across that virtual network let them systematically hunt for master molecular switches, genes powerful enough to redirect a cell’s entire identity, rather than stumbling onto one by luck. Three genes stood out as the key controls: HDAC2, FOXA2, and MYB.

When the team switched off those three genes in actual colon cancer cells in the lab, something remarkable happened. The cells slowed their runaway growth, dropped their aggressive behavior, and started resembling healthy intestinal tissue at the genetic level. Mice given these reprogrammed cells grew dramatically smaller tumors than mice given untreated cancer cells, and the team confirmed the reprogrammed cells looked genetically similar to normal colon tissue.

Think of it like flipping a handful of switches on a control panel that quietly steers a cell’s entire destiny, guiding it back onto the road it left instead of demolishing the vehicle. That distinction matters, since conventional treatments like chemotherapy kill cancer cells but often damage healthy ones too, causing the harsh side effects patients dread and leaving room for resistant cells to survive and return.

Would you rather see cancer treated by killing the cells or by reprogramming them back to normal?

MBH/PS

1 Like
2

The main aim of medicine is not just to increase life expectancy, but also to improve the quality of life. In cancer treatment, conventional approaches such as chemotherapy and radiotherapy can be effective, but they often come with significant side effects that can affect a patient’s daily life.

With advancements in medicine, newer approaches such as differentiation therapy /cancer cell reprogramming are being explored as potential ways to target cancer differently. However, these approaches are not without their own challenges and can also have significant side effects. More research and experimentation are needed to better understand these therapies and make them safer and more effective.

3

If we can treat cancer by reprogramming the cancer cells to their normal state and continue with contact inhibition. It will be a great breakthrough in cancer treatment and will reduce the post cancer complications immensely.
If cancer cell reprogramming is achievable in near future it is better than killing cancer cells.

4

If this experiment gets successful even on the larger animal models and thereby on humans as well then this way of a cancer treatment is much more better than chemotherapy where even healthy cells get affected.

5

I think reprogramming the cancer cells back to normal is a better option if research can prove it is safe and effective. Restoring their normal function can reduce damage to healthy tissues and lead to fewer side effects.